SCHEMBL6017716

SCHEMBL6017716

Cc1cc(C)c(CCC(N)=O)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.41
HRH3 Q9Y5N1 3/20 0.41
LMNA P02545 2/20 0.40
KDM4E B2RXH2 2/20 0.39
IDO1 P14902 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
CAPN1 P07384 1/20 0.37
F2 P00734 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
HTR1D P28221 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30946559 0.85 CYP3A4 (0.39) IDO1NPSR1CAPN1HTR1DHTT
SCHEMBL11392001 0.84 GPR17 (0.42) GPR17HRH3LMNAKDM4ENPSR1
SCHEMBL24747566 0.83 NPC1 (0.39) GPR17LMNAKDM4ENPSR1ALDH1A1
SCHEMBL14988768 0.83 NPSR1 (0.57) GPR17HRH3KDM4ENPSR1MAPT
SCHEMBL27964907 0.83 CAPN1 (0.46) LMNACAPN1PRSS1PRSS2PRSS3
SCHEMBL11099663 0.83 KDM4E (0.44) GPR17HRH3LMNAKDM4ENPSR1
SCHEMBL19594797 0.81 HRH3 (0.40) GPR17HRH3LMNAKDM4EF2
SCHEMBL777612 0.80 HTT (0.45) GPR17LMNAKDM4EF2PRSS1
SCHEMBL7193838 0.79 ALDH1A1 (0.42) GPR17HRH3LMNAKDM4ENPSR1
SCHEMBL14988847 0.79 LMNA (0.39) GPR17HRH3LMNAHTR1DGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708992-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES Pfizer Limited (GB) 2006-10-11 EP claimed
WO-2005080324-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES PFIZER LIMITED (GB) 2005-09-01 WO claimed
CN-114728906-A Novel chemical method for preparing key intermediate 6-chloro-4- (4-fluoro-2-methylphenyl) pyridine-3-amine of NT-814 康堤医疗有限公司 2022-07-08 CN disclosed
EP-1708992-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES Pfizer Limited (GB) 2006-10-11 EP disclosed
WO-2005080324-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES PFIZER LIMITED (GB) 2005-09-01 WO disclosed